A citation-based method for searching scientific literature

Iciar Aviles-Olmos, John Dickson, Zinovia Kefalopoulou, Atbin Djamshidian, Peter Ell, Therese Soderlund, Peter Whitton, Richard Wyse, Tom Isaacs, Andrew Lees, Patricia Limousin, Thomas Foltynie. J Clin Invest 2013
Times Cited: 281



Theresa R Bomfim, Leticia Forny-Germano, Luciana B Sathler, Jordano Brito-Moreira, Jean-Christophe Houzel, Helena Decker, Michael A Silverman, Hala Kazi, Helen M Melo, Paula L McClean, Christian Holscher, Steven E Arnold, Konrad Talbot, William L Klein, Douglas P Munoz, Sergio T Ferreira, Fernanda G De Felice. J Clin Invest 2012
Times Cited: 579




List of shared articles



Times cited

Impaired brain insulin signalling in Parkinson's disease.
Fares Bassil, Anna Delamarre, Marie-Hélène Canron, Nathalie Dutheil, Anne Vital, Marie-Laure Négrier-Leibreich, Erwan Bezard, Pierre-Olivier Fernagut, Wassilios G Meissner. Neuropathol Appl Neurobiol 2022
1

Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation.
Bruno Dutra Arbo, Lucia Emanueli Schimith, Michele Goulart Dos Santos, Mariana Appel Hort. Eur J Pharmacol 2022
0

Therapeutic application of GLP-1 and GIP receptor agonists in Parkinson's disease.
Xiaoyan Yang, Peng Feng, Rong Ji, Yiqing Ren, Wenshi Wei, Christian Hölscher. Expert Opin Ther Targets 2022
0




Proglucagon-Derived Peptides as Therapeutics.
Ryan A Lafferty, Finbarr P M O'Harte, Nigel Irwin, Victor A Gault, Peter R Flatt. Front Endocrinol (Lausanne) 2021
8

GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects.
Xin Zhao, Minghe Wang, Zhitong Wen, Zhihong Lu, Lijuan Cui, Chao Fu, Huan Xue, Yunfeng Liu, Yi Zhang. Front Endocrinol (Lausanne) 2021
7


Insulin and leptin as potential cognitive enhancers in metabolic disorders and Alzheimer's disease.
Diana C P Mejido, Julyanna A Peny, Marcelo N N Vieira, Sérgio T Ferreira, Fernanda G De Felice. Neuropharmacology 2020
14

GLP-1 receptor agonists for Parkinson's disease.
Caroline A Mulvaney, Gonçalo S Duarte, Joel Handley, David Jw Evans, Suresh Menon, Richard Wyse, Hedley Ca Emsley. Cochrane Database Syst Rev 2020
18

Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics.
Therese S Salameh, Elizabeth M Rhea, Konrad Talbot, William A Banks. Biochem Pharmacol 2020
21


The Dual GLP-1/GIP Receptor Agonist DA4-JC Shows Superior Protective Properties Compared to the GLP-1 Analogue Liraglutide in the APP/PS1 Mouse Model of Alzheimer's Disease.
Mark Maskery, Elizabeth Mary Goulding, Simon Gengler, Josefine Ulrikke Melchiorsen, Mette Marie Rosenkilde, Christian Hölscher. Am J Alzheimers Dis Other Demen 2020
11

Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's and Parkinson's Diseases.
Andre F Batista, Victor Bodart-Santos, Fernanda G De Felice, Sergio T Ferreira. CNS Drugs 2019
32

GLP-1's role in neuroprotection: a systematic review.
Damla Erbil, Candan Yasemin Eren, Cağrı Demirel, Mehmet Utku Küçüker, Ihsan Solaroğlu, Hale Yapıcı Eser. Brain Inj 2019
35